Natural Killer T cells
Springer-Verlag New York Inc.
978-1-4614-2950-0 (ISBN)
Preface.- Introduction: Mechanisms of NKT cell-mediated adjuvant activity and function of iPS-derived NKT cells.- Structure and Recognition of Antigens for Invariant NKT Cells.- Invariant NKT cell-based vaccine strategies.- Immune regulation of tumor immunity by NKT cells.- The Regulation of CD1d+ and CD1d- tumors by NKT Cells.- DC-based immunotherapy targeting NKT cells.- Therapeutic Approaches Utilising NKT Cells.- NKT Cells of Cancer Patients & How Models can Inform Therapeutic Plans.- Understanding the role of Natural Killer T (NKT) cells in hematologic malignancies: progress and challenges.- Clinical trials with α-galactosylceramide (KRN7000) in advanced cancer.- Clinical trials of invariant Natural Killer T cell-based immunotherapy for cancer.- Index.
Reihe/Serie | Cancer Drug Discovery and Development |
---|---|
Zusatzinfo | XII, 208 p. |
Verlagsort | New York, NY |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Medizin / Pharmazie ► Studium | |
Schlagworte | CD1d • dendric cells • iPS-Derived NKT Cells • Lymphoma • α-Galactosylceramide |
ISBN-10 | 1-4614-2950-1 / 1461429501 |
ISBN-13 | 978-1-4614-2950-0 / 9781461429500 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich